Kang Y, Siegel PM, Shu W, Drobnjak M, Kakonen SM, Cordon-Cardo C, Guise TA, Massague J: A multigenic program mediating breast cancer metastasis to bone. Cancer Cell. 2003, 3: 537-549. 10.1016/S1535-6108(03)00132-6.
Article
CAS
PubMed
Google Scholar
Chiang AC, Massague J: Molecular basis of metastasis. N Engl J Med. 2008, 359: 2814-2823. 10.1056/NEJMra0805239.
Article
PubMed Central
CAS
PubMed
Google Scholar
Minn AJ, Kang Y, Serganova I, Gupta GP, Giri DD, Doubrovin M, Ponomarev V, Gerald WL, Blasberg R, Massague J: Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. J Clin Invest. 2005, 115: 44-55.
Article
PubMed Central
CAS
PubMed
Google Scholar
Schmidt-Kittler O, Ragg T, Daskalakis A, Granzow M, Ahr A, Blankenstein TJ, Kaufmann M, Diebold J, Arnholdt H, Muller P, Bischoff J, Harich D, Schlimok G, Riethmuller G, Eils R, Klein CA: From latent disseminated cells to overt metastasis: genetic analysis of systemic breast cancer progression. Proc Natl Acad Sci USA. 2003, 100: 7737-7742. 10.1073/pnas.1331931100.
Article
PubMed Central
CAS
PubMed
Google Scholar
Husemann Y, Geigl JB, Schubert F, Musiani P, Meyer M, Burghart E, Forni G, Eils R, Fehm T, Riethmüller G, Klein CA: Systemic spread is an early step in breast cancer. Cancer Cell. 2008, 13: 58-68. 10.1016/j.ccr.2007.12.003.
Article
PubMed
Google Scholar
Nguyen DX, Bos PD, Massague J: Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer. 2009, 9: 274-284. 10.1038/nrc2622.
Article
CAS
PubMed
Google Scholar
Feller L, Bouckaert M, Chikte UM, Wood NH, Khammissa RA, Meyerov R, Lemmer J: A short account of cancer--specifically in relation to squamous cell carcinoma. SADJ. 2010, 65: 322-324.
CAS
PubMed
Google Scholar
Logothetis CJ, Lin SH: Osteoblasts in prostate cancer metastasis to bone. Nat Rev Cancer. 2005, 5: 21-28. 10.1038/nrc1528.
Article
CAS
PubMed
Google Scholar
Nguyen DX, Massague J: Genetic determinants of cancer metastasis. Nat Rev Genet. 2007, 8: 341-352.
Article
CAS
PubMed
Google Scholar
Roato I, Grano M, Brunetti G, Colucci S, Mussa A, Bertetto O, Ferracini R: Mechanisms of spontaneous osteoclastogenesis in cancer with bone involvement. FASEB J. 2005, 19: 228-230.
CAS
PubMed
Google Scholar
Major PP, Cook RJ, Lipton A, Smith MR, Terpos E, Coleman RE: Natural history of malignant bone disease in breast cancer and the use of cumulative mean functions to measure skeletal morbidity. BMC Cancer. 2009, 9: 272-10.1186/1471-2407-9-272.
Article
PubMed Central
PubMed
Google Scholar
Sun YX, Fang M, Wang J, Cooper CR, Pienta KJ, Taichman RS: Expression and activation of alpha v beta 3 integrins by SDF-1/CXC12 increases the aggressiveness of prostate cancer cells. Prostate. 2007, 67: 61-73. 10.1002/pros.20500.
Article
CAS
PubMed
Google Scholar
Wels J, Kaplan RN, Rafii S, Lyden D: Migratory neighbors and distant invaders: tumor-associated niche cells. Genes Dev. 2008, 22: 559-574. 10.1101/gad.1636908.
Article
PubMed Central
CAS
PubMed
Google Scholar
Wang J, Loberg R, Taichman RS: The pivotal role of CXCL12 (SDF-1)/CXCR4 axis in bone metastasis. Cancer Metastasis Rev. 2006, 25: 573-587.
Article
CAS
PubMed
Google Scholar
Taichman RS, Loberg RD, Mehra R, Pienta KJ: The evolving biology and treatment of prostate cancer. J Clin Invest. 2007, 117: 2351-2361. 10.1172/JCI31791.
Article
PubMed Central
CAS
PubMed
Google Scholar
Kaplan RN, Rafii S, Lyden D: Preparing the "soil": the premetastatic niche. Cancer Res. 2006, 66: 11089-11093. 10.1158/0008-5472.CAN-06-2407.
Article
PubMed Central
CAS
PubMed
Google Scholar
Pienta KJ, Loberg R: The "emigration, migration, and immigration"of prostate cancer. Clin Prostate Cancer. 2005, 4: 24-30.
Article
PubMed
Google Scholar
Sun YX, Schneider A, Jung Y, Wang J, Dai J, Cook K, Osman NI, Koh-Paige AJ, Shim H, Pienta KJ, Keller ET, McCauley LK, Taichman RS: Skeletal localization and neutralization of the SDF-1(CXCL12)/CXCR4 axis blocks prostate cancer metastasis and growth in osseous sites in vivo. J Bone Miner Res. 2005, 20: 318-329.
Article
CAS
PubMed
Google Scholar
Guise TA, Kozlow WM, Heras-Herzig A, Padalecki SS, Yin JJ, Chirgwin JM: Molecular mechanisms of breast cancer metastases to bone. Clin Breast Cancer. 2005, 5: S46-S53. 10.3816/CBC.2005.s.004.
Article
CAS
PubMed
Google Scholar
Mundy GR: Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer. 2002, 2: 584-593. 10.1038/nrc867.
Article
CAS
PubMed
Google Scholar
Schwartz GG: Prostate cancer, serum parathyroid hormone, and the progression of skeletal metastases. Cancer Epidemiol Biomarkers Prev. 2008, 17: 478-483. 10.1158/1055-9965.EPI-07-2747.
Article
CAS
PubMed
Google Scholar
Tian E, Zhan F, Walker R, Rasmussen E, Ma Y, Barlogie B, Shaughnessy JD: The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma. N Engl J Med. 2003, 349: 2483-2494. 10.1056/NEJMoa030847.
Article
CAS
PubMed
Google Scholar
Dai J, Keller J, Zhang J, Lu Y, Yao Z, Keller ET: Bone morphogenetic protein-6 promotes osteoblastic prostate cancer bone metastases through a dual mechanism. Cancer Res. 2005, 65: 8274-8285. 10.1158/0008-5472.CAN-05-1891.
Article
CAS
PubMed
Google Scholar
Li ZG, Yang J, Vazquez ES, Rose D, Vakar-Lopez F, Mathew P, Lopez A, Logothetis CJ, Lin SH, Navone NM: Low-density lipoprotein receptor-related protein 5 (LRP5) mediates the prostate cancer-induced formation of new bone. Oncogene. 2008, 27: 596-603. 10.1038/sj.onc.1210694.
Article
CAS
PubMed
Google Scholar
Keller ET, Zhang J, Cooper CR, Smith PC, McCauley LK, Pienta KJ, Taichman RS: Prostate carcinoma skeletal metastases: cross-talk between tumor and bone. Cancer Metastasis Rev. 2001, 20: 333-349. 10.1023/A:1015599831232.
Article
CAS
PubMed
Google Scholar
Brown JE, Coleman RE: The present and future role of bisphosphonates in the management of patients with breast cancer. Breast Cancer Res. 2002, 4: 24-29.
Article
PubMed Central
CAS
PubMed
Google Scholar
Brown JE, Neville-Webbe H, Coleman RE: The role of bisphosphonates in breast and prostate cancers. Endocr Relat Cancer. 2004, 11: 207-224. 10.1677/erc.0.0110207.
Article
CAS
PubMed
Google Scholar
Bringhurst F, Demay M, Krane S, Kronenberg H: Bone and Mineral Metabolism in Health and Disease. Harrison's Principles of Internal Medicine. Edited by: Kasper D, Hauser S, Longo D, Jameson J, Loscaizo J. 2008, New York: McGraw-Hill, 2365-2376. 17
Google Scholar
Koeneman KS, Yeung F, Chung LW: Osteomimetic properties of prostate cancer cells: a hypothesis supporting the predilection of prostate cancer metastasis and growth in the bone environment. Prostate. 1999, 39: 246-261. 10.1002/(SICI)1097-0045(19990601)39:4<246::AID-PROS5>3.0.CO;2-U.
Article
CAS
PubMed
Google Scholar
Bai YD, Yang FS, Xuan K, Bai YX, Wu BL: Inhibition of RANK/RANKL signal transduction pathway: a promising approach for osteoporosis treatment. Med Hypotheses. 2008, 71: 256-258. 10.1016/j.mehy.2008.03.021.
Article
CAS
PubMed
Google Scholar
Roodman GD: Mechanisms of bone metastasis. N Engl J Med. 2004, 350: 1655-1664. 10.1056/NEJMra030831.
Article
CAS
PubMed
Google Scholar
Glass DA, Bialek P, Ahn JD, Starbuck M, Patel MS, Clevers H, Taketo MM, Long F, McMahon AP, Lang RA, Karsenty G: Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Dev Cell. 2005, 8: 751-764. 10.1016/j.devcel.2005.02.017.
Article
CAS
PubMed
Google Scholar
Romas E: Clinical applications of RANK-ligand inhibition. Intern Med J. 2009, 39: 110-116. 10.1111/j.1445-5994.2008.01732.x.
Article
CAS
PubMed
Google Scholar
Fenton R, Longo D: Cancer Cell Biology and Angiogenesis. Harrison's Principles of Internal Medicine. Edited by: Kasper D, Hauser S, Longo D, Jameson J, Loscaizo J. 2008, New York: McGraw-Hill, 498-513. 17
Google Scholar
Biskobing DM, Fan X, Rubin J: Characterization of MCSF-induced proliferation and subsequent osteoclast formation in murine marrow culture. J Bone Miner Res. 1995, 10: 1025-1032.
Article
CAS
PubMed
Google Scholar
Yagiz K, Rittling SR: Both cell-surface and secreted CSF-1 expressed by tumor cells metastatic to bone can contribute to osteoclast activation. Exp Cell Res. 2009, 315: 2442-2452. 10.1016/j.yexcr.2009.05.002.
Article
PubMed Central
CAS
PubMed
Google Scholar
Guise TA, Mohammad KS, Clines G, Stebbins EG, Wong DH, Higgins LS, Vessella R, Corey E, Padalecki S, Suva L, Chirgwin JM: Basic mechanisms responsible forb osteolytic and osteoblastic bone metastases. Clin Cancer Res. 2006, 12: 6213s-6216s. 10.1158/1078-0432.CCR-06-1007.
Article
CAS
PubMed
Google Scholar
Guise TA: Molecular mechanisms of osteolytic bone metastases. Cancer. 2000, 88: 2892-2898. 10.1002/1097-0142(20000615)88:12+<2892::AID-CNCR2>3.0.CO;2-Y.
Article
CAS
PubMed
Google Scholar
Yoneda T: Cellular and molecular basis of preferential metastasis of breast cancer to bone. J Orthop Sci. 2000, 5: 75-81. 10.1007/s007760050012.
Article
CAS
PubMed
Google Scholar
Lelekakis M, Moseley JM, Martin TJ, Hards D, Williams E, Ho P, Lowen D, Javni J, Miller FR, Slavin J, Anderson RL: A novel orthotopic model of breast cancer metastasis to bone. Clin Exp Metastasis. 1999, 17: 163-170. 10.1023/A:1006689719505.
Article
CAS
PubMed
Google Scholar
Jacob K, Webber M, Benayahu D, Kleinman HK: Osteonectin promotes prostate cancer cell migration and invasion: a possible mechanism for metastasis to bone. Cancer Res. 1999, 59: 4453-4457.
CAS
PubMed
Google Scholar
Roato I, D'Amelio P, Gorassini E, Grimaldi A, Bonello L, Fiori C, Delsedime L, Tizzani A, De Libero A, Isaia G, Ferracini R: Osteoclasts are active in bone forming metastases of prostate cancer patients. PloS one. 2008, 3: e3627-10.1371/journal.pone.0003627.
Article
PubMed Central
PubMed
Google Scholar
Darby S, Cross SS, Brown NJ, Hamdy FC, Robson CN: BMP-6 over-expression in prostate cancer is associated with increased Id-1 protein and a more invasive phenotype. J Pathol. 2008, 214: 394-404. 10.1002/path.2292.
Article
CAS
PubMed
Google Scholar
Chung LW, Baseman A, Assikis V, Zhau HE: Molecular insights into prostate cancer progression: the missing link of tumor microenvironment. J Urol. 2005, 173: 10-20. 10.1097/01.ju.0000141582.15218.10.
Article
PubMed
Google Scholar
Loberg RD, Logothetis CJ, Keller ET, Pienta KJ: Pathogenesis and treatment of prostate cancer bone metastases: targeting the lethal phenotype. J Clin Oncol. 2005, 23: 8232-8241. 10.1200/JCO.2005.03.0841.
Article
CAS
PubMed
Google Scholar
Feller L, Wood NH, Khammissa RA, Chikte UM, Bouckaert M, Lemmer J: Bisphosphonate-related osteonecrosis of the jaw. SADJ. 2011, 66: 30-32.
CAS
PubMed
Google Scholar
Barton MK: Denosumab an option for patients with bone metastasis from breast cancer. CA Cancer J Clin. 2011, 61: 135-136. 10.3322/caac.20116.
Article
PubMed
Google Scholar
Coleman R, Brown J, Terpos E, Lipton A, Smith MR, Cook R, Major P: Bone markers and their prognostic value in metastatic bone disease: clinical evidence and future directions. Cancer Treat Rev. 2008, 34: 629-639. 10.1016/j.ctrv.2008.05.001.
Article
PubMed Central
CAS
PubMed
Google Scholar
Brown JE, Cook RJ, Major P, Lipton A, Saad F, Smith M, Lee KA, Zheng M, Hei YJ, Coleman RE: Bone turnover markers as predictors of skeletal complications in prostate cancer, lung cancer, and other solid tumors. J Natl Cancer Inst. 2005, 97: 59-69. 10.1093/jnci/dji002.
Article
CAS
PubMed
Google Scholar
Seibel MJ: Clinical use of markers of bone turnover in metastatic bone disease. Nat Clin Pract Oncol. 2005, 2: 504-517.
Article
CAS
PubMed
Google Scholar
Seibel MJ: The use of molecular markers of bone turnover in the management of patients with metastatic bone disease. Clin Endocrinol. 2008, 68: 839-849. 10.1111/j.1365-2265.2007.03112.x.
Article
CAS
Google Scholar
Cremers S, Garnero P: Biochemical markers of bone turnover in the clinical development of drugs for osteoporosis and metastatic bone disease: potential uses and pitfalls. Drugs. 2006, 66: 2031-2058. 10.2165/00003495-200666160-00001.
Article
CAS
PubMed
Google Scholar
Huang Q, Ouyang X: Biochemical-markers for the diagnosis of bone metastasis: A review in clinical. Cancer Epidemiol. 2011
Google Scholar
Hirshberg A, Leibovich P, Buchner A: Metastatic tumors to the jawbones: analysis of 390 cases. J Oral Pathol Med. 1994, 23: 337-341. 10.1111/j.1600-0714.1994.tb00072.x.
Article
CAS
PubMed
Google Scholar
D'Silva NJ, Summerlin DJ, Cordell KG, Abdelsayed RA, Tomich CE, Hanks CT, Fear D, Meyrowitz S: Metastatic tumors in the jaws: a retrospective study of 114 cases. J Am Dent Assoc. 2006, 137: 1667-1672.
Article
PubMed
Google Scholar
Hirshberg A, Shnaiderman-Shapiro A, Kaplan I, Berger R: Metastatic tumours to the oral cavity - pathogenesis and analysis of 673 cases. Oral Oncol. 2008, 44: 743-752. 10.1016/j.oraloncology.2007.09.012.
Article
PubMed
Google Scholar
Irani S: Metastasis to head and neck area: a 16-year retrospective study. Am J Otolaryngol. 2011, 32: 24-27. 10.1016/j.amjoto.2009.09.006.
Article
PubMed
Google Scholar
van der Waal RI, Buter J, van der Waal I: Oral metastases: report of 24 cases. Br J Oral Maxillofac Surg. 2003, 41: 3-6. 10.1016/S0266-4356(02)00301-7.
Article
CAS
PubMed
Google Scholar
Ertas U, Yalcin E, Erdogan F: Invasive ductal carcinoma with multiple metastases to facial and cranial bones: a case report. Eur J Dent. 2010, 4: 334-337.
PubMed Central
PubMed
Google Scholar
Katsnelson A, Tartakovsky JV, Miloro M: Review of the literature for mandibular metastasis illustrated by a case of lung metastasis to the temporomandibular joint in an HIV-positive patient. J Oral Maxillofac Surg. 2010, 68: 1960-1964. 10.1016/j.joms.2009.07.075.
Article
PubMed
Google Scholar